In several myeloid and lymphoid malignancies, driver mutations bringing about constitutive JAK activation can be found. The paradigm is represented by BCR-ABL1Autonomous activation from the JAK/STAT pathway is central in many pathologies. Genetic alterations targeting this signaling pathway are affiliated mostly with hematologic malignancies. Patho… Read More